GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Todos Medical Ltd (OTCPK:TOMDF) » Definitions » Debt-to-EBITDA

Todos Medical (Todos Medical) Debt-to-EBITDA : -4.20 (As of Sep. 2022)


View and export this data going back to 2017. Start your Free Trial

What is Todos Medical Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Todos Medical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2022 was $5.86 Mil. Todos Medical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2022 was $30.02 Mil. Todos Medical's annualized EBITDA for the quarter that ended in Sep. 2022 was $-8.55 Mil. Todos Medical's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2022 was -4.20.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Todos Medical's Debt-to-EBITDA or its related term are showing as below:

TOMDF's Debt-to-EBITDA is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 1.915
* Ranked among companies with meaningful Debt-to-EBITDA only.

Todos Medical Debt-to-EBITDA Historical Data

The historical data trend for Todos Medical's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Todos Medical Debt-to-EBITDA Chart

Todos Medical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Debt-to-EBITDA
Get a 7-Day Free Trial -0.50 -1.48 -0.36 -0.70 -2.28

Todos Medical Quarterly Data
Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.53 -0.73 - -3.50 -4.20

Competitive Comparison of Todos Medical's Debt-to-EBITDA

For the Diagnostics & Research subindustry, Todos Medical's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Todos Medical's Debt-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Todos Medical's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Todos Medical's Debt-to-EBITDA falls into.



Todos Medical Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Todos Medical's Debt-to-EBITDA for the fiscal year that ended in Dec. 2021 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(2.023 + 29.729) / -13.944
=-2.28

Todos Medical's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2022 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(5.857 + 30.015) / -8.548
=-4.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2022) EBITDA data.


Todos Medical  (OTCPK:TOMDF) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Todos Medical Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Todos Medical's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Todos Medical (Todos Medical) Business Description

Traded in Other Exchanges
N/A
Address
121 Derech Menachem Begin, 30th Floor, Tel Aviv, ISR, 6701203
Todos Medical Ltd is an in vitro diagnostics company. Its operating segments are Breast Cancer Test, Alzheimer's, and COVID-19 testing. The company generates all of its revenue from the United States.
Executives
Gerald Commissiong director, officer: CEO and Director 675 ALMANOR AVENUE, SUNNYVALE CA 94085
Strategic Investment Holdings, Llc 10 percent owner 875 CARRETERA 693, SUITE 201, DORADO PR 00646